Cargando…

Mass Spectrometry and Biomarker Development

Detalles Bibliográficos
Autor principal:	Rodland, Karin D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2004
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839273/ https://www.ncbi.nlm.nih.gov/pubmed/15502244 http://dx.doi.org/10.1155/2004/569810

Ejemplares similares

Characterization of Plasma Membrane Proteins from Ovarian Cancer Cells Using Mass Spectrometry
por: Springer, David L., et al.
Publicado: (2004)

Absolute Quantification of Choline-Related Biomarkers in Breast Cancer Biopsies by Liquid Chromatography Electrospray Ionization Mass Spectrometry
por: Mimmi, Maria Chiara, et al.
Publicado: (2013)

Heart Disease, Clinical Proteomics and Mass Spectrometry
por: Stanley, Brian A., et al.
Publicado: (2004)

Discovery of Ovarian Cancer Biomarkers in Serum Using NanoLC Electrospray Ionization TOF and FT-ICR Mass Spectrometry
por: Bergen, H. Robert, et al.
Publicado: (2004)

Laser-assisted decay spectroscopy and mass spectrometry of $^{178}\mathrm{Au}$
por: Cubiss, J G, et al.
Publicado: (2020)

Antibody-Free Mass Spectrometry Identification of Vascular Integrity Markers in Major Trauma
por: Hinson, H.E., et al.
Publicado: (2021)

Systems Biology and Biomarker Discovery
por: Rodland, Karin D.
Publicado: (2010)

International Symposium on Accelerator Mass Spectrometry
por: Gove, H E, et al.
Publicado: (1987)

Quadrupole storage mass spectrometry
por: March, Raymond E, et al.
Publicado: (1989)

Workshop in Accelerator Mass Spectrometry
Publicado: (1986)

A Rational Approach for Discovering and Validating Cancer Markers in Very Small Samples Using Mass Spectrometry and ELISA Microarrays
por: Zangar, Richard C., et al.
Publicado: (2004)

Spectrometrie de masse: principes et applications
por: Constantin, Emilia
Publicado: (1996)

11th International Mass Spectrometry Conference
por: Longevialle, P
Publicado: (1988)

Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma
por: Kennedy, Jacob J., et al.
Publicado: (2022)

Polysialylated N-Glycans Identified in Human Serum Through Combined Developments in Sample Preparation, Separations, and Electrospray Ionization-Mass Spectrometry
por: Kronewitter, Scott R., et al.
Publicado: (2014)

3rd International Symposium on Accelerator Mass Spectrometry
por: Andersen, Hans Henrik, et al.
Publicado: (1984)

Proceedings of the NATO Advanced Study Institute on Mass Spectrometry in the Biological Sciences : A Tutorial
por: Gross, Michael
Publicado: (1992)

Circulating Cancer Biomarkers
por: Lokshin, Anna, et al.
Publicado: (2021)

NATO Advanced Study Institute on Mass Spectrometry in Biomolecular Sciences
por: Caprioli, Richard, et al.
Publicado: (1996)

4th International Conference on Secondary Ion Mass Spectrometry
por: Benninghoven, A, et al.
Publicado: (1984)

A bibliography of mass spectrometry references: PDP 95 and addendum
por: Atomic Energy of Canada. Chalk River
Publicado: (1953)

32nd Annual Conference on Mass Spectrometry and Related Topics
Publicado: (1984)

18e Journées Francaises de Spectrometrie de Masse
Publicado: (2001)

13e Journées Françaises de Spéctrometrie de Masse
Publicado: (1996)

Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
por: Ryu, Joohyun, et al.
Publicado: (2021)

Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteins
por: Shi, Tujin, et al.
Publicado: (2017)

Human Neutrophil Peptides 1–3 as Gastric Cancer Tissue Markers Measured by MALDI-Imaging Mass Spectrometry: Implications for Infiltrated Neutrophils as a Tumor Target
por: Cheng, Chun-Chia, et al.
Publicado: (2012)

Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007)

Mass spectrometry for the detection of potential psychiatric biomarkers
por: Ngounou Wetie, Armand G, et al.
Publicado: (2013)

Measurement Reproducibility in the Early Stages of Biomarker Development
por: Liggett, Walter S., et al.
Publicado: (2004)

Overview of Biomarkers and Surrogate Endpoints in Drug Development
por: Wagner, John A.
Publicado: (2002)

The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery
por: Shen, Eric Yi-Liang, et al.
Publicado: (2023)

Biomarkers and Surrogate Endpoints: How and When might They Impact Drug Development?
por: Lathia, Chetan D.
Publicado: (2002)

Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics
por: Chen, Yi-Ting, et al.
Publicado: (2018)

The Ramsey method in high-precision mass spectrometry with Penning traps: Experimental results
por: George, S, et al.
Publicado: (2007)

Detection of Pancreatic Cancer Biomarkers Using Mass Spectrometry
por: Kim, Kiyoun, et al.
Publicado: (2015)

Advances in mass spectrometry-based clinical biomarker discovery
por: Crutchfield, Christopher A., et al.
Publicado: (2016)

Mass Spectrometry Reveals Respiratory Viral Infection Biomarkers
por: Na, Chan Hyun, et al.
Publicado: (2017)

Biomarkers for Lysosomal Storage Disorders with an Emphasis on Mass Spectrometry
por: Mashima, Ryuichi, et al.
Publicado: (2020)

QT Interval Prolongation as a Biomarker for Torsades de Pointes and Sudden Death in Drug Development
por: Sides, Gregory D.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_uuucse3in1bb963hfuepnhjsvp